TFF Pharmaceuticals, Inc.
TFFP · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $8,789 | $6,528 | $15,306 | $16,608 |
| - Cash | $2,607 | $4,387 | $3,212 | $5,478 |
| + Debt | $52 | $74 | $95 | $115 |
| Enterprise Value | $6,235 | $2,215 | $12,190 | $11,245 |
| Revenue | $193 | $650 | $203 | $734 |
| % Growth | -70.3% | 219.9% | -72.3% | – |
| Gross Profit | $193 | $510 | $63 | $603 |
| % Margin | 100% | 78.4% | 31% | 82.2% |
| EBITDA | -$3,582 | -$3,822 | -$5,595 | -$5,238 |
| % Margin | -1,852.3% | -587.8% | -2,752.4% | -713.8% |
| Net Income | -$3,545 | -$4,479 | -$5,735 | -$4,762 |
| % Margin | -1,833.1% | -688.9% | -2,821.4% | -648.9% |
| EPS Diluted | -0.81 | -1.22 | -2.4 | -2.01 |
| % Growth | 33.6% | 49.2% | -19.4% | – |
| Operating Cash Flow | -$1,980 | -$3,253 | -$3,144 | -$4,214 |
| Capital Expenditures | $0 | $0 | $0 | -$46 |
| Free Cash Flow | -$1,980 | -$3,253 | -$3,144 | -$4,260 |